3D-Printed Hand Orthosis for ADL in Chronic Hand Conditions
Official title: Cost-effectiveness of 3D-printed Hand Orthoses for Activities of Daily Living in Chronic Hand Conditions
Run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · NCT07633821 · Data updated 2026-11-12
This study tests whether a 3D-printed hand orthosis works as well as a traditional plaster-cast orthosis for improving daily activities in adults with chronic hand conditions.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Academic / other |
| Locations | 1 site (Amsterdam, North Holland) |
| Status | Recruiting |
| Started | September 14, 2026 |
| Main results expected | May 2030 |
| Study ends | September 2030 |
| Registry record updated | September 30, 2026 |
| Trial ID | NCT07633821 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with a chronic, stable hand condition from a neurological, musculoskeletal, neuromuscular disorder, or injury, who need a first or repeat circular thumb, wrist, or wrist-thumb orthosis for permanent use to help ADLs.
✕Probably not a fit
Individuals not needing a functional hand orthosis or those with non-functional hands may not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In adults with chronic hand conditions, researchers compare a 3D-printed orthosis to a conventional plaster-cast orthosis to see how well each supports daily activities and hand function. The study builds on prior evidence suggesting similar outcomes but faster production and higher satisfaction with 3D-printed devices. Participants are adults requiring a circular thumb, wrist, or wrist-thumb orthosis for permanent use to aid everyday tasks. The design includes a direct comparison between the two orthosis types and considers cost-effectiveness alongside functional and quality-of-life measures. Conducted at Amsterdam UMC with support from ZonMw, the trial aims to provide robust data on feasibility, patient experience, and potential benefits of 3D printing in orthotic care.
Why it matters
Potential benefit: If successful, 3D-printed orthoses could save time and resources while maintaining or improving hand function and daily activities for patients.
How similar studies have gone: Earlier feasibility work showed comparable outcomes between 3D-printed and conventional orthoses, with faster production and higher user satisfaction for the 3D-printed option.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with a chronic, stable hand condition due to a neurological disorder, musculoskeletal disorder, neuromuscular disease or injury; * Minimum age of 18 years; * Indicated for a first or repeat prescription of a circular thumb, wrist or wrist-thumb orthosis for permanent use for improving ADL performance. Exclusion Criteria: * Indicated for an orthosis for a non-functional hand; * Insufficient mastery of the Dutch language.
Where it's running
-
Amsterdam UMC, location AMC
Amsterdam, North Holland, Netherlands Recruiting
Study contacts
- Principal investigator: Merel-Anne Brehm, PhD — Amsterdam UMC, location AMC
- Study coordinator: Tanja Oud, PhD
- Email: t.a.oud@amsterdamumc.nl
- Phone: 31 20 5662615
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Registering medical data and care outcomes for ALS, SMA, and other motor disorders
This registry slowly collects routine-care information from adults with ALS, SMA, or other motor disorders to see how they’re treated and how care affects outcomes.
-
How chronic pain changes over time in kids with Duchenne Muscular Dystrophy
This study is following children and teens with Duchenne Muscular Dystrophy for 6 months to see how their chronic pain changes and how it affects daily life.
-
Able Kids device: safer gait aid for kids with neurologic gait problems
This study tests whether the ABLE Kids wearable exoskeleton can be safely used during a 10-session gait training program for children with neurological gait disorders or muscle weakness.
-
Zeleciment Rostudirsen (DYNE-251) for Duchenne Muscular Dystrophy in Ambulatory Boys
This trial tests whether intravenous Zeleciment Rostudirsen (DYNE-251) given every 4 weeks is safe and helps improve function in ambulatory boys with Duchenne muscular dystrophy who have a specific dystrophin gene mutation.
-
AOC 1044 in Duchenne Muscular Dystrophy with Exon 44 Skipping
This study tests whether intravenous AOC 1044 helps boys with Duchenne muscular dystrophy caused by mutations amenable to exon 44 skipping.
-
Northwestern Neuromuscular Disease Biobank
This project will collect blood, skin, spinal fluid, and clinical information from adults with neuromuscular diseases seen at Northwestern to create a shared resource for research.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.